Anti-hypertensive Drugs Market 2019 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2024 – ABC…

Posted: Published on January 18th, 2020

This post was added by Alex Diaz-Granados

Antihypertensive drugs are referred to as a class of drugs that are used in treating hypertension (high blood pressure). There are many classes of antihypertensive drugs, which have the ability to lower blood pressure by different means, and thus, prevent the complications associated with high blood pressure, including stroke and myocardial infarction.

The Report Covers:

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/14099123

Key Market Trends:

Diuretics is Expected to Hold a Significant Market Share in the Therapeutic Class

Thiazide diuretics are the cornerstone of treatment for hypertension in most patients. Hydrochlorothiazide is the most commonly used thiazide diuretic in the United States. The Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure recommends thiazide-type diuretics to be one of the preferred drug treatments for hypertension, whether used on its own or along with other antihypertensive drugs, such as calcium channel blockers. Moreover, it was also noted that more than one-third of the adults affected by hypertension were reported to take diuretics.

North America Dominates the Market and is Expected to do Same during the Forecast Period

According to the AHA (American heart association), 74.9% of hypertension patients are currently undergoing treatment, and only 52.2% of patients have it under control. AHA projection shows that by 2030, about 41.4% of adults in the United States are expected to have hypertension. The demand for prompt and accurate diagnosis, and treatment of hypertension, identifying people predisposed to the disease, presence of technically advanced healthcare infrastructure, and management of the prognosis of the disease are some of the key market drivers of the North American anti-hypertension market.

Key Questions Answered in This Report:

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14099123

Detailed TOC of Anti-hypertensive Drugs Market 2019-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Increasing Prevalence of Hypertension 4.2.2 Growing Initiatives by Private and Government Organizations 4.2.3 Rising Awareness about Hypertension 4.3 Market Restraints 4.3.1 Multiple Major Drug Patent Expiration 4.3.2 Side-effects of Treatment Options 4.3.3 Rise in Non-pharmacological Therapy 4.4 Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 Therapeutic Class 5.1.1 Diuretics 5.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors 5.1.3 Angiotensin Receptor Blockers (ARBs) 5.1.4 Beta Blockers 5.1.5 Alpha Blockers 5.1.6 Renin Inhibitors 5.1.7 Calcium Channel Blockers 5.1.8 Other Therapeutic Classes 5.2 Geography 5.2.1 North America 5.2.1.1 United States 5.2.1.2 Canada 5.2.1.3 Mexico 5.2.2 Europe 5.2.2.1 Germany 5.2.2.2 United Kingdom 5.2.2.3 France 5.2.2.4 Italy 5.2.2.5 Spain 5.2.2.6 Rest of Europe 5.2.3 Asia-Pacific 5.2.3.1 China 5.2.3.2 Japan 5.2.3.3 India 5.2.3.4 Australia 5.2.3.5 South korea 5.2.3.6 Rest of Asia-Pacific 5.2.4 Middle East & Africa 5.2.4.1 GCC 5.2.4.2 South Africa 5.2.4.3 Rest of Middle East & Africa 5.2.5 South America 5.2.5.1 Brazil 5.2.5.2 Argentina 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Astrazeneca PLC 6.1.2 Boehringer Ingelheim 6.1.3 Daiichi Sankyo Company Limited 6.1.4 Johnson & Johnson Ltd 6.1.5 Lupin Limited 6.1.6 Merck & Co. Inc. 6.1.7 Novartis AG 6.1.8 Pfizer Inc. 6.1.9 Ranbaxy Laboratories Limited 6.1.10 Sanofi SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

PC Monitor Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2025

Isinglass Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2023

Upcoming Trends of LiDAR Market 2019 Covers Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight by Leading Key Players Forecast till 2024

Non-contact Thermometer Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional by Forecast to 2025

Wind Power Equipment Industry:2019 Market Research with Size, Growth, Manufacturers, Segments and 2025 Forecasts Research

Global Warehouse Ladders Market Size & share 2019: Subdivision by, Challenges and Key Findings Forecast 2025

See the original post here:
Anti-hypertensive Drugs Market 2019 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2024 - ABC...

Related Posts
This entry was posted in Hypertension. Bookmark the permalink.

Comments are closed.